Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)

SHA:600420 Revenue

Shanghai Shyndec Pharmaceutical had revenue of 1.65B CNY in the quarter ending September 30, 2026, a decrease of -19.46%. This brings the company's total for the last twelve months to 8.03B, down -13.35% year-over-year. In the year 2025, Shanghai Shyndec Pharmaceutical had annual revenue of 9.36B, down -14.39%. That makes Shanghai Shyndec Pharmaceutical the 6,850th largest company in the world by revenue and 968th in China.

• Revenue (ttm): 8.03B
• Revenue Growth: -13.35%
• P/S Ratio: 1.38
• Revenue / Employee: 827.88K
• Employees: 9,697
• Market Cap: 11.12B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 2.34B 25.1%
• Overseas 1.91B 20.5%
• Southern China 1.27B 13.6%
• North China 1.21B 13.0%
• Central China 918.69M 9.9%
• South-West China 876.14M 9.4%
• North-West China 401.12M 4.3%
• North-East China 397.53M 4.3%

Fiscal year ended Dec 31, 2025 See the full SHA:600420 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.36B	-1.57B	-14.39%
Dec 31, 2024	10.94B	-1.13B	-9.38%
Dec 31, 2023	12.07B	-889.39M	-6.86%
Dec 31, 2022	12.96B	-985.63M	-7.07%
Dec 31, 2021	13.94B	1.39B	11.06%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error